CGM and a dedicated handheld controller or smartphone application to automate dosing. In 2017, Lilly started working with Dexcom on the partnership, which aims to combine devices, drugs and ...

Analyst Price Forecast Suggests 14.60% Upside As of January 28, 2025, the average one-year price target for DexCom is $99.51/share. The forecasts range from a low of $75.75 to a high of $131.25.